Related Experiment Video
Updated: Feb 13, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Longitudinally extensive transverse myelitis with pulmonary tuberculosis: Two case reports.
Yu Zhang1, Mingqin Zhu, Lifang Wang
1Department of Neurology and Neuroscience Center, the First Hospital of Jilin University, Changchun, China.
Longitudinally extensive transverse myelitis (LETM) associated with pulmonary tuberculosis (PTB) showed improved outcomes with combined corticosteroid and anti-tuberculosis therapy. This treatment approach may offer a better prognosis for LETM patients with PTB.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Longitudinally extensive transverse myelitis (LETM) involves spinal cord inflammation across at least three vertebral segments.
- While often idiopathic, LETM can stem from infections or autoimmune conditions.
- Neuromyelitis Optic Spectrum Disorder (NMOSD) is a frequent cause of LETM, with reported associations with pulmonary tuberculosis (PTB).
Observation:
- Two patients with LETM and a history of PTB were studied.
- Patient 1, anti-aquaporin-4 antibody (AQP4-Ab) positive NMOSD, presented with limb weakness and sensory deficits.
- Patient 2, anti-AQP4-Ab negative LETM, experienced lower limb and chest numbness.
Findings:
- Both patients received a combination of corticosteroids and anti-tuberculosis drugs.
- Follow-up up to one year demonstrated reduced spinal cord lesion size.
- Both patients showed improvement in their Expanded Disability Status Scale (EDSS) scores.
Implications:
- Combined corticosteroid and anti-tuberculosis treatment may improve outcomes for LETM patients with PTB.
- This therapeutic strategy could offer a better prognosis in managing co-occurring LETM and PTB.
- Further research is warranted to confirm these findings in larger cohorts.
More Related Videos
10:06Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
Published on: February 26, 2018
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Longitudinal Research